Patent Assignment
Reel/Frame 059006/0629
Merger
Recorded: 2022-02-14
Pages: 8
Assignor
CHIASMA, INC.
Executed: 2021-08-05
Assignee
AMRYT ENDO, INC.
140 KENDRICK STREET, BUILDING C EAST, NEEDHAM, MASSACHUSETTS, 02494
Covered Property
(1)
Oral Octreotide for the Treatment of Disease
Application:
16/071,630 →
Publication:
US 2021/0187079
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Feb 18, 2022
From: AMRYT ENDO, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059048/0944 →
Release of Security Interest
Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →
Change of Address
Mar 19, 2024
From: MCEVOY, JOHN
To: AMRYT ENDO, INC.
Reel/Frame 066833/0786 →